Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold von Neumann, Peter J, Cohen, Joshua T, Weinstein, Milton C

Volltext

It Is Time to Reconsider the 3% Discount Rate von Cohen, Joshua T.

Volltext

The Impact on Cost-Effectiveness of Accounting for Generic Drug Pricing: Four Case Studies von Cohen, Joshua T.

Volltext

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer von Tie, Jeanne, Cohen, Joshua D., Lahouel, Kamel, Lo, Serigne N., Wang, Yuxuan, Kosmider, Suzanne, Wong, Rachel, Shapiro, Jeremy, Lee, Margaret, Harris, Sam, Khattak, Adnan, Burge, Matthew, Harris, Marion, Lynam, James, Nott, Louise, Day, Fiona, Hayes, Theresa, McLachlan, Sue-Anne, Lee, Belinda, Ptak, Janine, Silliman, Natalie, Dobbyn, Lisa, Popoli, Maria, Hruban, Ralph, Lennon, Anne Marie, Papadopoulos, Nicholas, Kinzler, Kenneth W., Vogelstein, Bert, Tomasetti, Cristian, Gibbs, Peter

Volltext

QALYs in 2018—Advantages and Concerns von Neumann, Peter J, Cohen, Joshua T

Volltext

Institutionalizing public engagement in research and innovation: Toward the construction of institutional entrepreneurial collectives von Cohen, Joshua B

Volltext

Measuring the Value of Prescription Drugs von Neumann, Peter J, Cohen, Joshua T

Volltext

Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018 von Kim, David D., Silver, Madison C., Kunst, Natalia, Cohen, Joshua T., Ollendorf, Daniel A., Neumann, Peter J.

Volltext

Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters von Cheung, Kevin J., Padmanaban, Veena, Silvestri, Vanesa, Schipper, Koen, Cohen, Joshua D., Fairchild, Amanda N., Gorin, Michael A., Verdone, James E., Pienta, Kenneth J., Bader, Joel S., Ewald, Andrew J.

Volltext

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted von Neumann, Peter J, Thorat, Teja, Zhong, Yue, Anderson, Jordan, Farquhar, Megan, Salem, Mark, Sandberg, Eileen, Saret, Cayla J, Wilkinson, Colby, Cohen, Joshua T

Volltext

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study von Goadsby, Peter J., Silberstein, Stephen D., Yeung, Paul P., Cohen, Joshua M., Ning, Xiaoping, Yang, Ronghua, Dodick, David W.

Volltext

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, pl... von Ferrari, Michel D, Diener, Hans Christoph, Ning, Xiaoping, Galic, Maja, Cohen, Joshua M, Yang, Ronghua, Mueller, Matthias, Ahn, Andrew H, Schwartz, Yael Carmeli, Grozinski-Wolff, Melissa, Janka, Lindsay, Ashina, Messoud

Volltext

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study von Silberstein, Stephen D., Cohen, Joshua M., Seminerio, Michael J., Yang, Ronghua, Ashina, Sait, Katsarava, Zaza

Volltext

Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer von Senguttuvan, Rosemary N, Cohen, Joshua G

Volltext

Sex-specific effects of 17β-estradiol and dihydrotestosterone (DHT) on growth plate chondrocytes are dependent on both ERα and ERβ and require palmitoylation to translocate the rec... von Joshua Cohen, D., ElBaradie, Khairat, Boyan, Barbara D., Schwartz, Zvi

Volltext

Is There a Future for Value-Based Contracting? von Cohen, Joshua P.

Volltext

Adherence to the iDSI reference case among published cost-per-DALY averted studies von Emerson, Joanna, Panzer, Ari, Cohen, Joshua T, Chalkidou, Kalipso, Teerawattananon, Yot, Sculpher, Mark, Wilkinson, Thomas, Walker, Damian, Neumann, Peter J, Kim, David D

Volltext

Letter to the editor regarding “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database” von Kessler, Yoel, Ning, Xiaoping, Cohen, Joshua M

Volltext

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs von Bilinski, Alyssa, Neumann, Peter, Cohen, Joshua, Thorat, Teja, McDaniel, Katherine, Salomon, Joshua A

Volltext

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies von Leech, Ashley A., Kim, David D., Cohen, Joshua T., Neumann, Peter J.

Volltext